为病人提供药物来那度胺药物别名REVLIMID.PDFVIP

Traditional Chinese 為病人提供的藥物：來那度胺 藥物別名：REVLIMID® For the Patient: Lenalidomide Other names: REVLIMID® • 來那度胺(Lenalidomide, 英文讀音len a lid oh mide) 是一種用來醫治多類癌症的藥物。這是口 服膠囊藥片。 Lenalidomide (len a lid oh mide) is a drug that is used to treat several types of cancer. It is a capsule that you take by mouth. • 在服食來那度胺之前，如果您曾經對來那度胺或thalidomide (THALOMID®)有異常或過敏反 應 ，請告訴醫生。 Tell your doctor if you have ever had an unusual or allergic reaction to lenalidomide or thalidomide (THALOMID®) before taking lenalidomide. • 在接受來那度胺之前，您先要在RevAid®計劃登記 ，這個計劃屬於來那度胺製造商運作的控 制藥物分發計劃。 Before receiving lenalidomide you will be registered with the RevAid® Program, a distribution control program run by the manufacturer of lenalidomide. • 在接受每次治療前，可能需要進行一次驗血 ，您的化療劑量及時間，可能會根據您的驗血結 果及/或有否其他副作用而更改。 A blood test may be taken before each treatment. The dose and timing of your chemotherapy may be changed based on the test results and/or other side effects. • 如果您是女性，並能夠懷孕，則在開始進行來那度胺的療程之前，先會驗血兩次 ，以確定您 是否有孕。在療程首四個星期，每個星期也會驗血一次，然後每隔四個星期會再驗血一次。 If you are a woman and are able to bear children, a blood test to determine whether you are pregnant will be taken twice before starting lenalidomide treatment, weekly for the first 4 weeks of treatment, and then repeated every four weeks. • 女性在懷孕期間服用來那度胺，可能對嬰兒有害。可能令腹中胎兒造成嚴重先天缺陷或死 亡。在接受此療程期間、以及服用最後一劑來那度胺之後的四個星期，必須同時採取兩種可 靠的節育方式。如果您懷孕，請立即通知醫生。切勿在接受治療期間餵哺母乳。 Lenalidomide may harm the baby if used during pregnancy. Severe birth defects or death to the unborn baby may occur. Two forms of reliable birth control must be used at the same time during treatment and for 4 weeks after your last dose of lenalidomide. Tell your doctor right away if you